Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

     
Available items only
E-Books/E-Docs
Corporate Author United States. Government Accountability Office, author.

Title Medicare program integrity, CMS pursues many practices to address prescription drug fraud, waste, and abuse : report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives.

Publication Info. [Washington, D.C.] : United States Government Accountability Office, 2014.

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  GA 1.13:GAO-15-66    ---  Available
Description 1 online resource (ii, 34 pages) : color illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Note Title from title screen (viewed on September 15, 2016).
"October 2014."
"GAO-15-66."
Bibliography Includes bibliographical references.
Summary Recent media reports and law enforcement actions have highlighted the problem of prescription drug fraud, waste, and abuse in the United States. Medicare, and the Part D prescription drug benefit, are susceptible to such fraud--a risk made greater by Medicare's size, scope, and complexity. GAO and others have raised questions about CMS's oversight of its activities to address fraud, waste, and abuse in Part D, as well as oversight of the contractors tasked with this work. GAO examined (1) practices for promoting prescription drug program integrity, and (2) the extent that CMS's oversight of Medicare Part D program integrity, including the program integrity contractors, reflects these practices. To develop a list of practices, GAO interviewed 14 stakeholder groups involved in various aspects of prescription drug program integrity, including provider, beneficiary, and anti-fraud groups; identified and reviewed related documents; and conducted a search of eight bibliographic databases that included peer-reviewed articles and government documents. GAO organized the practices based on the three categories of GAO's Fraud Prevention Framework. To determine how CMS's oversight reflects these practices, GAO analyzed agency documents, such as contracts, manuals, work products, and CMS audits of contractors; and interviewed agency officials.
Subject Centers for Medicare & Medicaid Services (U.S.) -- Rules and practice.
Centers for Medicare & Medicaid Services (U.S.) (OCoLC)fst00767996
Medicare fraud -- Prevention.
Medication abuse -- United States -- Prevention.
Waste in government spending -- United States.
Medicare fraud -- Prevention. (OCoLC)fst01014849
Medication abuse -- Prevention. (OCoLC)fst01014858
Waste in government spending. (OCoLC)fst01171026
United States. (OCoLC)fst01204155
Genre/Form Internet resources.
Rules. (OCoLC)fst01423857
Electronic government information.
Electronic books.
Added Author United States. Congress. House. Committee on Ways and Means. Subcommittee on Health, sponsoring body.
Added Title CMS pursues many practices to address prescription drug fraud, waste, and abuse
Medicare program integrity, Centers for Medicare and Medicaid Services' pursues many practices to address prescription drug fraud, waste, and abuse
Gpo Item No. 0546-D (online)
Sudoc No. GA 1.13:GAO-15-66

 
    
Available items only